{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:09:30Z","timestamp":1793506170666,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T00:00:00Z","timestamp":1708992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T00:00:00Z","timestamp":1708992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["23 2655 Pj"],"award-info":[{"award-number":["23 2655 Pj"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2023-02106"],"award-info":[{"award-number":["2023-02106"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006313","name":"Barncancerfonden","doi-asserted-by":"publisher","award":["PR2023-0078"],"award-info":[{"award-number":["PR2023-0078"]}],"id":[{"id":"10.13039\/501100006313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004635","name":"Fru Berta Kamprads Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004635","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011077","name":"Sk\u00e5nes universitetssjukhus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011077","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Governmental funding of clinical research within the national health services, ALF"},{"name":"The CanFaster Program","award":["EU-MSCA-COFUND"],"award-info":[{"award-number":["EU-MSCA-COFUND"]}]},{"name":"The CanFaster Program","award":["754299"],"award-info":[{"award-number":["754299"]}]},{"name":"The Viveca Jeppsson Foundation"},{"DOI":"10.13039\/501100003252","name":"Lund University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Immunotherapies with antibody\u2013drug-conjugates (ADC) and CAR-T cells, targeted at tumor surface antigens (surfaceome), currently revolutionize clinical oncology. However, target identification warrants a better understanding of the surfaceome and how it is modulated by the tumor microenvironment. Here, we decode the surfaceome and endocytome and its remodeling by hypoxic stress in glioblastoma (GBM), the most common and aggressive brain tumor in adults. We employed a comprehensive approach for global and dynamic profiling of the surfaceome and endocytosed (endocytome) proteins and their regulation by hypoxia in patient-derived GBM cultures. We found a heterogeneous surface-endocytome profile and a divergent response to hypoxia across GBM cultures. We provide a quantitative ranking of more than 600 surface resident and endocytosed proteins, and their regulation by hypoxia, serving as a resource to the cancer research community. As proof-of-concept, the established target antigen CD44 was identified as a commonly and abundantly expressed surface protein with high endocytic activity. Among hypoxia induced proteins, we reveal CXADR, CD47, CD81, BSG, and FXYD6 as potential targets of the stressed GBM niche. We could validate these findings by immunofluorescence analyses in patient tumors and by increased expression in the hypoxic core of GBM spheroids. Selected candidates were finally confronted by treatment studies, showing their high capacity for internalization and ADC delivery. Importantly, we highlight the limited correlation between transcriptomics and proteomics, emphasizing the critical role of membrane protein enrichment strategies and quantitative mass spectrometry. Our findings provide a comprehensive understanding of the surface-endocytome and its remodeling by hypoxia in GBM as a resource for exploration of targets for immunotherapeutic approaches in GBM.<\/jats:p>","DOI":"10.1186\/s40478-024-01740-z","type":"journal-article","created":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T05:02:13Z","timestamp":1709010133000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Decoding of the surfaceome and endocytome in primary glioblastoma cells identifies potential target antigens in the hypoxic tumor niche"],"prefix":"10.1186","volume":"12","author":[{"given":"Kelin Gon\u00e7alves","family":"de Oliveira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"B\u00e5ng-Rudenstam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Boukredine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Talbot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Governa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Sofie","family":"M\u00e5nsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Forsberg-Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Bengzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Malmstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Welinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1585-5434","authenticated-orcid":false,"given":"Mattias","family":"Belting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,27]]},"reference":[{"key":"1740_CR1","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1093\/neuonc\/noaa106","volume":"22","author":"PY Wen","year":"2020","unstructured":"Wen PY, Weller M, Lee EQ, Alexander BM, Barnholtz-Sloan JS, Barthel FP et al (2020) Glioblastoma in adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions. Neuro Oncol 22:1073\u20131113","journal-title":"Neuro Oncol"},{"key":"1740_CR2","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","volume":"178","author":"C Neftel","year":"2019","unstructured":"Neftel C, Laffy J, Filbin MG, Hara T, Shore ME, Rahme GJ et al (2019) An integrative model of cellular states, plasticity, and genetics for glioblastoma. Cell 178:835-849.e21","journal-title":"Cell"},{"key":"1740_CR3","doi-asserted-by":"publisher","first-page":"V1","DOI":"10.1093\/neuonc\/noz150","volume":"21","author":"QT Ostrom","year":"2019","unstructured":"Ostrom QT, Cioffi G, Gittleman H, Patil N, Waite K, Kruchko C et al (2019) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012\u20132016. Neuro Oncol 21:V1-100","journal-title":"Neuro Oncol"},{"key":"1740_CR4","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/nrc2540","volume":"8","author":"JA Bertout","year":"2008","unstructured":"Bertout JA, Patel SA, Simon MC (2008) The impact of O2 availability on human cancer. Nat Rev Cancer 8:967\u2013975","journal-title":"Nat Rev Cancer"},{"key":"1740_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2049-3002-2-3","volume":"2","author":"N Masson","year":"2014","unstructured":"Masson N, Ratcliffe PJ (2014) Hypoxia signaling pathways in cancer metabolism: the importance of co-selecting interconnected physiological pathways. Cancer Metab 2:1\u201317","journal-title":"Cancer Metab"},{"key":"1740_CR6","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/j.1582-4934.2010.01016.x","volume":"14","author":"Y Wang","year":"2010","unstructured":"Wang Y, Ohh M (2010) Oxygen-mediated endocytosis in cancer. J Cell Mol Med 14:496\u2013503","journal-title":"J Cell Mol Med"},{"key":"1740_CR7","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1158\/1541-7786.MCR-20-0560","volume":"19","author":"M Cerezo-Maga\u00f1a","year":"2021","unstructured":"Cerezo-Maga\u00f1a M, Christianson HC, van Kuppevelt TH, Forsberg-Nilsson K, Belting M (2021) Hypoxic induction of exosome uptake through proteoglycan-dependent endocytosis fuels the lipid droplet phenotype in Glioma. Mol Cancer Res 19:528\u2013540","journal-title":"Mol Cancer Res"},{"key":"1740_CR8","doi-asserted-by":"crossref","unstructured":"Zhang MS, Cui J Di, Lee D, Yuen VWH, Chiu DKC, Goh CC, et al (2022) Hypoxia-induced macropinocytosis represents a metabolic route for liver cancer. Nat Commun 13","DOI":"10.1038\/s41467-022-28618-9"},{"key":"1740_CR9","doi-asserted-by":"crossref","unstructured":"Drago JZ, Modi S, Chandarlapaty S (2021) Unlocking the potential of antibody\u2013drug conjugates for cancer therapy. Nat Rev Clin Oncol 327\u201344","DOI":"10.1038\/s41571-021-00470-8"},{"key":"1740_CR10","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s43018-023-00516-z","volume":"4","author":"S Zinn","year":"2023","unstructured":"Zinn S, Vazquez-Lombardi R, Zimmermann C, Sapra P, Jermutus L, Christ D (2023) Advances in antibody-based therapy in oncology. Nat Cancer 4:165\u2013180","journal-title":"Nat Cancer"},{"key":"1740_CR11","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1158\/2159-8290.CD-20-0242","volume":"11","author":"MA Nix","year":"2021","unstructured":"Nix MA, Mandal K, Geng H, Paranjape N, Lin YHT, Rivera JM et al (2021) Surface proteomics reveals CD72 as a target for in vitro\u2013evolved nanobody-based CAR-T cells in KMT2A\/MLL1-rearranged B-ALL. Cancer Discov 11:2032\u20132049","journal-title":"Cancer Discov"},{"key":"1740_CR12","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature10098","volume":"473","author":"B Schwanh\u00e4usser","year":"2011","unstructured":"Schwanh\u00e4usser B, Busse D, Li N, Dittmar G, Schuchhardt J, Wolf J et al (2011) Global quantification of mammalian gene expression control. Nature 473:337\u2013342","journal-title":"Nature"},{"key":"1740_CR13","doi-asserted-by":"crossref","unstructured":"Governa V, Talbot H, Gon\u00e7alves de Oliveira K, Cerezo-Maga\u00f1a M, B\u00e5ng-Rudenstam A, Johansson MC, et al (2022) Landscape of surfaceome and endocytome in human glioma is divergent and depends on cellular spatial organization. Proc Natl Acad Sci USA 119","DOI":"10.1073\/pnas.2114456119"},{"key":"1740_CR14","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.ebiom.2015.08.026","volume":"2","author":"Y Xie","year":"2015","unstructured":"Xie Y, Bergstr\u00f6m T, Jiang Y, Johansson P, Marinescu VD, Lindberg N et al (2015) The human glioblastoma cell culture resource: validated cell models representing all molecular subtypes. EBioMedicine 2:1351\u20131363","journal-title":"EBioMedicine"},{"key":"1740_CR15","doi-asserted-by":"crossref","unstructured":"Clark MJ, Homer N, O\u2019Connor BD, Chen Z, Eskin A, Lee H, et al (2010) U87MG decoded: the genomic sequence of a cytogenetically aberrant human cancer cell line. PLoS Genet 6","DOI":"10.1371\/journal.pgen.1000832"},{"key":"1740_CR16","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha VK, Lindgren CM, Eriksson K-F, Subramanian A, Sihag S, Lehar J et al (2003) PGC-1\u03b1-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34:267\u2013273","journal-title":"Nat Genet"},{"key":"1740_CR17","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102:15545\u201315550","journal-title":"Proc Natl Acad Sci USA"},{"key":"1740_CR18","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","volume":"17","author":"RG Verhaak","year":"2010","unstructured":"Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD et al (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17:98\u2013110","journal-title":"Cancer Cell"},{"key":"1740_CR19","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ccell.2017.06.003","volume":"32","author":"Q Wang","year":"2017","unstructured":"Wang Q, Hu B, Hu X, Kim H, Squatrito M, Scarpace L et al (2017) Tumor Evolution of glioma-intrinsic gene expression subtypes associates with immunological changes in the microenvironment. Cancer Cell 32:42\u201356","journal-title":"Cancer Cell"},{"key":"1740_CR20","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1093\/neuonc\/noy024","volume":"20","author":"S Baskaran","year":"2018","unstructured":"Baskaran S, Mayrhofer M, Kultima HG, Bergstr\u00f6m T, Elfineh L, Cavelier L et al (2018) Primary glioblastoma cells for precision medicine: a quantitative portrait of genomic (in)stability during the first 30 passages. Neuro Oncol 20:1080\u20131091","journal-title":"Neuro Oncol"},{"key":"1740_CR21","doi-asserted-by":"publisher","first-page":"8879","DOI":"10.1074\/jbc.M309802200","volume":"279","author":"I Watanabe","year":"2004","unstructured":"Watanabe I, Zhu J, Recio-Pinto E, Thornhill WB (2004) Glycosylation affects the protein stability and cell surface expression of Kv1.4 but Not Kv1.1 potassium channels. A pore region determinant dictates the effect of glycosylation on trafficking. J Biol Chem 279:8879\u20138885","journal-title":"J Biol Chem"},{"key":"1740_CR22","doi-asserted-by":"publisher","first-page":"66960","DOI":"10.18632\/oncotarget.16921","volume":"8","author":"HC Christianson","year":"2017","unstructured":"Christianson HC, Menard JA, Chandran VI, Bourseau-Guilmain E, Shevela D, Lidfeldt J et al (2017) Tumor antigen glycosaminoglycan modification regulates antibody-drug conjugate delivery and cytotoxicity. Oncotarget 8:66960\u201366974","journal-title":"Oncotarget"},{"key":"1740_CR23","doi-asserted-by":"publisher","first-page":"E10988","DOI":"10.1073\/pnas.1808790115","volume":"115","author":"D Bausch-Fluck","year":"2018","unstructured":"Bausch-Fluck D, Goldmann U, M\u00fcller S, van Oostrum M, M\u00fcller M, Schubert OT et al (2018) The in silico human surfaceome. Proc Natl Acad Sci USA 115:E10988\u2013E10997","journal-title":"Proc Natl Acad Sci USA"},{"key":"1740_CR24","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1158\/0008-5472.CAN-17-2429","volume":"78","author":"W Xiao","year":"2018","unstructured":"Xiao W, Zhang R, Sohrabi A, Ehsanipour A, Sun S, Liang J et al (2018) Brain-mimetic 3D culture platforms allow investigation of cooperative effects of extracellular matrix features on therapeutic resistance in glioblastoma. Cancer Res 78:1358\u20131370","journal-title":"Cancer Res"},{"key":"1740_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jocn.2016.05.012","volume":"34","author":"KL Mooney","year":"2016","unstructured":"Mooney KL, Choy W, Sidhu S, Pelargos P, Bui TT, Voth B et al (2016) The role of CD44 in glioblastoma multiforme. J Clin Neurosci 34:1\u20135","journal-title":"J Clin Neurosci"},{"key":"1740_CR26","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ccr.2013.08.001","volume":"24","author":"KPL Bhat","year":"2013","unstructured":"Bhat KPL, Balasubramaniyan V, Vaillant B, Ezhilarasan R, Hummelink K, Hollingsworth F et al (2013) Mesenchymal differentiation mediated by NF-\u03baB promotes radiation resistance in glioblastoma. Cancer Cell 24:331\u2013346","journal-title":"Cancer Cell"},{"key":"1740_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers14143297","volume":"14","author":"PC McDonald","year":"2022","unstructured":"McDonald PC, Chafe SC, Supuran CT, Dedhar S (2022) Cancer therapeutic targeting of hypoxia induced carbonic anhydrase IX: from bench to bedside. Cancers (Basel) 14:1\u20137","journal-title":"Cancers (Basel)"},{"key":"1740_CR28","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1126\/science.275.5304.1320","volume":"275","author":"JM Bergelson","year":"1997","unstructured":"Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS et al (1997) Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 275:1320\u20131323","journal-title":"Science"},{"key":"1740_CR29","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1158\/0008-5472.CAN-11-3185","volume":"72","author":"S Miyamoto","year":"2012","unstructured":"Miyamoto S, Inoue H, Nakamura T, Yamada M, Sakamoto C, Urata Y et al (2012) Coxsackievirus B3 is an oncolytic virus with immunostimulatory properties that is active against lung adenocarcinoma. Cancer Res 72:2609\u20132621","journal-title":"Cancer Res"},{"key":"1740_CR30","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1042\/BST20221203","volume":"51","author":"C Owczarek","year":"2023","unstructured":"Owczarek C, Elmasry Y, Parsons M (2023) Contributions of coxsackievirus adenovirus receptor to tumorigenesis. Biochem Soc Trans 51:1143\u20131155","journal-title":"Biochem Soc Trans"},{"key":"1740_CR31","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1126\/science.282.5390.938","volume":"282","author":"P Pileri","year":"1998","unstructured":"Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R et al (1998) Binding of hepatitis C Virus to CD81. Science 282:938\u2013941","journal-title":"Science"},{"key":"1740_CR32","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1042\/BST20160478","volume":"45","author":"F Vences-Catal\u00e1n","year":"2017","unstructured":"Vences-Catal\u00e1n F, Duault C, Kuo CC, Rajapaksa R, Levy R, Levy S (2017) CD81 as a tumor target. Biochem Soc Trans 45:531\u2013535","journal-title":"Biochem Soc Trans"},{"key":"1740_CR33","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1084\/jem.20190186","volume":"216","author":"F Vences-Catal\u00e1n","year":"2019","unstructured":"Vences-Catal\u00e1n F, Kuo CC, Rajapaksa R, Duault C, Andor N, Czerwinski DK et al (2019) CD81 is a novel immunotherapeutic target for B cell lymphoma. J Exp Med 216:1497\u20131508","journal-title":"J Exp Med"},{"key":"1740_CR34","doi-asserted-by":"crossref","unstructured":"Vences-Catal\u00e1n F, Rajapaksa R, Kuo CC, Miller CL, Lee A, Ramani VC, et al (2021) Targeting the tetraspanin CD81 reduces cancer invasion and metastasis. Proc Natl Acad Sci USA 118","DOI":"10.1073\/pnas.2018961118"},{"key":"1740_CR35","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1093\/neuonc\/nos298","volume":"15","author":"V Miranda-Gon\u00e7alves","year":"2013","unstructured":"Miranda-Gon\u00e7alves V, Honavar M, Pinheiro C, Martinho O, Pires MM, Pinheiro C et al (2013) Monocarboxylate transporters (MCTs) in gliomas: Expression and exploitation as therapeutic targets. Neuro Oncol 15:172\u2013188","journal-title":"Neuro Oncol"},{"key":"1740_CR36","doi-asserted-by":"crossref","unstructured":"Zhang P, Rashidi A, Zhao J, Silvers C, Wang H, Castro B, et al (2023) STING agonist-loaded, CD47\/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma. Nat Commun 14","DOI":"10.1038\/s41467-023-37328-9"},{"key":"1740_CR37","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1073\/pnas.1520032112","volume":"112","author":"H Zhang","year":"2015","unstructured":"Zhang H, Lu H, Xiang L, Bullen JW, Zhang C, Samanta D et al (2015) HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells. Proc Natl Acad Sci USA 112:215\u2013223","journal-title":"Proc Natl Acad Sci USA"},{"key":"1740_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/sciadv.aaz6119","volume":"6","author":"A Thakur","year":"2020","unstructured":"Thakur A, Qiu G, Xu C, Han X, Yang T, Ng SP et al (2020) Label-free sensing of exosomal MCT1 and CD147 for tracking metabolic reprogramming and malignant progression in glioma. Sci Adv 6:1\u201317","journal-title":"Sci Adv"},{"key":"1740_CR39","doi-asserted-by":"crossref","unstructured":"Murali M, Kumar AR, Nair B, Pavithran K, Devan AR, Pradeep GK, et al (2022) Antibody\u2013drug conjugate as targeted therapeutics against hepatocellular carcinoma: preclinical studies and clinical relevance. Clin Transl Oncol 407\u2013431","DOI":"10.1007\/s12094-021-02707-5"},{"key":"1740_CR40","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1007\/s13238-014-0045-0","volume":"5","author":"Q Gao","year":"2014","unstructured":"Gao Q, Chen X, Duan H, Wang Z, Feng J, Yang D et al (2014) FXYD6: a novel therapeutic target toward hepatocellular carcinoma. Prot Cell 5:532\u2013543","journal-title":"Prot Cell"},{"key":"1740_CR41","first-page":"813","volume":"61","author":"JT Douglas","year":"2001","unstructured":"Douglas JT, Kim M, Sumerel LA, Carey DE, Curiel DT (2001) Efficient oncolysis by a replicating adenovirus (ad) in vivo is critically dependent on tumor expression of primary Ad receptors. Cancer Res 61:813\u2013817","journal-title":"Cancer Res"},{"key":"1740_CR42","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1093\/molehr\/gal081","volume":"12","author":"M Sullivan","year":"2006","unstructured":"Sullivan M, Galea P, Latif S (2006) What is the appropriate oxygen tension for in vitro culture? Mol Hum Reprod 12:653","journal-title":"Mol Hum Reprod"},{"key":"1740_CR43","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0034-5687(01)00306-1","volume":"128","author":"M Ereci\u0144ska","year":"2001","unstructured":"Ereci\u0144ska M, Silver IA (2001) Tissue oxygen tension and brain sensitivity to hypoxia. Respir Physiol 128:263\u2013276","journal-title":"Respir Physiol"},{"key":"1740_CR44","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41568-023-00574-6","volume":"23","author":"B Banushi","year":"2023","unstructured":"Banushi B, Joseph SR, Lum B, Lee JJ, Simpson F (2023) Endocytosis in cancer and cancer therapy. Nat Rev Cancer 23:450\u2013473","journal-title":"Nat Rev Cancer"},{"key":"1740_CR45","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1042\/BJ20111377","volume":"441","author":"G-M Shen","year":"2012","unstructured":"Shen G-M, Zhao Y-Z, Chen M-T, Zhang F-L, Liu X-L, Wang Y et al (2012) Hypoxia-inducible factor-1 (HIF-1) promotes LDL and VLDL uptake through inducing VLDLR under hypoxia. Biochem J 441:675\u2013683","journal-title":"Biochem J"},{"key":"1740_CR46","doi-asserted-by":"publisher","first-page":"26695","DOI":"10.1074\/jbc.M109.033480","volume":"284","author":"BR Mwaikambo","year":"2009","unstructured":"Mwaikambo BR, Yang C, Chemtob S, Hardy P (2009) Hypoxia up-regulates CD36 expression and function via hypoxia-inducible factor-1-and phosphatidylinositol 3-kinase-dependent mechanisms. J Biol Chem 284:26695\u201326707","journal-title":"J Biol Chem"},{"key":"1740_CR47","doi-asserted-by":"publisher","first-page":"4828","DOI":"10.1158\/0008-5472.CAN-15-2831","volume":"76","author":"JA Menard","year":"2016","unstructured":"Menard JA, Christianson HC, Kucharzewska P, Bourseau-Guilmain E, Svensson KJ, Lindqvist E et al (2016) Metastasis stimulation by hypoxia and acidosis-induced extracellular lipid uptake is mediated by proteoglycan-dependent endocytosis. Cancer Res 76:4828\u20134840","journal-title":"Cancer Res"},{"key":"1740_CR48","doi-asserted-by":"crossref","unstructured":"H\u00e4nsch L, Peipp M, Mastall M, Villars D, Myburgh R, Silginer M, et al (2023) Chimeric antigen receptor T cell-based targeting of CD317 as a novel immunotherapeutic strategy against glioblastoma. Neuro Oncol","DOI":"10.1093\/neuonc\/noad108"},{"key":"1740_CR49","doi-asserted-by":"crossref","unstructured":"van Solinge TS, Nieland L, Chiocca EA, Broekman MLD (2022) Advances in local therapy for glioblastoma\u2014taking the fight to the tumour. Nat Rev Neurol 221\u2013236","DOI":"10.1038\/s41582-022-00621-0"},{"key":"1740_CR50","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.1158\/2159-8290.CD-22-0837","volume":"12","author":"G Jerusalem","year":"2022","unstructured":"Jerusalem G, Park YH, Yamashita T, Hurvitz SA, Modi S, Andre F et al (2022) Trastuzumab deruxtecan in HER2-positive metastatic breast cancer patients with brain metastases: A DESTINY-Breast01 subgroup analysis. Cancer Discov 12:2754\u20132762","journal-title":"Cancer Discov"},{"key":"1740_CR51","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/s41571-023-00756-z","volume":"20","author":"MJ Mair","year":"2023","unstructured":"Mair MJ, Bartsch R, Le Rhun E, Berghoff AS, Brastianos PK, Cortes J et al (2023) Understanding the activity of antibody\u2013drug conjugates in primary and secondary brain tumours. Nat Rev Clin Oncol 20:372\u2013389","journal-title":"Nat Rev Clin Oncol"},{"key":"1740_CR52","doi-asserted-by":"crossref","unstructured":"Anami Y, Otani Y, Xiong W, Ha SYY, Yamaguchi A, Rivera-Caraballo KA, et al (2022) Homogeneity of antibody-drug conjugates critically impacts the therapeutic efficacy in brain tumors. Cell Rep 39","DOI":"10.1016\/j.celrep.2022.110839"},{"key":"1740_CR53","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S1470-2045(23)00112-2","volume":"24","author":"AM Sonabend","year":"2023","unstructured":"Sonabend AM, Gould A, Amidei C, Ward R, Schmidt KA, Zhang DY et al (2023) Repeated blood\u2013brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trial. Lancet Oncol 24:509\u2013522","journal-title":"Lancet Oncol"},{"key":"1740_CR54","doi-asserted-by":"publisher","first-page":"E8717","DOI":"10.1073\/pnas.1807105115","volume":"115","author":"CD Arvanitis","year":"2018","unstructured":"Arvanitis CD, Askoxylakis V, Guo Y, Datta M, Kloepper J, Ferraro GB et al (2018) Mechanisms of enhanced drug delivery in brain metastases with focused ultrasound-induced blood\u2013tumor barrier disruption. Proc Natl Acad Sci U S A 115:E8717\u2013E8726","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1740_CR55","first-page":"50","volume":"2021","author":"Y Perez-Riverol","year":"2022","unstructured":"Perez-Riverol Y, Bai J, Bandla C, Garc\u00eda-Seisdedos D, Hewapathirana S, Kamatchinathan S, The PRIDE, database resources in, et al (2022) a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res 2021:50","journal-title":"Nucleic Acids Res"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-024-01740-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-024-01740-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-024-01740-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T11:11:23Z","timestamp":1709032283000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-024-01740-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,27]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1740"],"URL":"https:\/\/doi.org\/10.1186\/s40478-024-01740-z","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,27]]},"assertion":[{"value":"13 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Written consent was signed by each patient in accordance with the approved ethical permit from the regional Swedish ethics committee (Dnr 2018\/37).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35"}}